Ondansetron 4 mg tablet

, ONDANSETRON HCL DIHYDRATE, JAMP-ONDANSETRON 4 MG ORAL TABLET ; , ONDANSETRON HCL DIHYDRATE, MAR-ONDANSETRON 4 MG ORAL TABLET ;

Tablets, 4 mg and 8 mg ondansetron (as ondansetron hydrochloride dihydrate), oral Each tablet contains 4 mg ondansetron (as hydrochloride

Ondansetron Tablets Ondansetron tablets USP, 4 mg (ondansetron hydrochloride USP, equivalent to 4 mg of ondansetron) are white, round, biconvex, film coated tablets

PAR Ondansetron 4 mg and 8 mg Tablets PL / Informed Consent, Regulation 56 2 LAY SUMMARY Ondansetron 4 mg Tablets Ondansetron 8 mg Tablets (Ondansetron hydrochloride dihydrate) This is a summary of the Public Assessment Report (PAR) for Ondansetron 4 mg and 8 mg Tablets.

Ondansetron Tablets Ondansetron tablets USP, 4 mg (ondansetron hydrochloride USP, equivalent to 4 mg of ondansetron) are white, round, biconvex, film coated tablets

Tablets, 4 mg and 8 mg ondansetron (as ondansetron hydrochloride dihydrate), oral ONDANSETRON Tablets 4 mg: Oval shaped, yellow, unscored

Ondansetron-DRLA tablets Ondansetron ODT-DRLA tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ondansetron hydrochloride dihydrate tablets 4 mg and 8 mg Ondansetron 4 mg and 8 mg orodispersible tablets 3 PHARMACEUTICAL FORM Ondansetron-DRLA tablets 4 mg: Light yellow, oval, biconvex film coated tablet embossed

Each 4 mg ondansetron tablet, USP for oral administration contains ondansetron hydrochloride dihydrate equivalent to 4 mg of ondansetron. Each 8 mg ondansetron tablet

ondansetron 8 mg orally disintegrating tablet, 4; ondansetron 8 mg orally disintegrating tablet, 10; ondansetron 4 mg tablet, 4; ondansetron 4 mg tablet, 10;